Brief: YS Biopharma To Hold EGM On May 21, 2024, Appoints Interim CEO
07/05/2024 23:10
May 7 (Reuters) - YS Biopharma Co Ltd H6Z.F :
* YS BIOPHARMA TO HOLD EXTRAORDINARY GENERAL MEETING ON MAY
21,
2024 AND ANNOUNCES THE APPOINTMENT OF INTERIM CHIEF EXECUTIVE
OFFICER
Source text for Eikon: ID:nPn1jcxhRa
Further company coverage: H6Z.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LakeShore Biopharma Co
See all newsBrief: LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
Brief: LakeShore Biopharma Appoints Advisors to Special Committee Reviewing Takeover Bid
Brief: Lakeshore Biopharma Announces Receipt Of A Preliminary Non-Binding Proposal To Acquire The Company
Brief: Lakeshore Biopharma Expects 2026 Revenue To Be Between RMB550 Million And RMB650 Million
Brief: Lakeshore Biopharma Announces Us$15 Million Private Placement Financing